DURHAM, N.C., Sept. 27, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) will showcase for the first time its DERMACYTE oxygen-rich skin care products at the Spa & Resort/Medical Aesthetics Spa Conference and Expo at the Jacob K. Javits Convention Center in New York City starting tomorrow. The conference is open to the public from 10 AM to 5 PM on September 28-29, 2010. Free DERMACYTE Oxygen Concentrate samples will be available while supplies last at our Booth #5020.
DERMACYTE Oxygen Concentrate is a scientifically designed, proprietary cream made to enhance oxygen delivery to skin. It is the first product in a broad and diverse cosmetic line currently under development by Oxygen Biotherapeutics. It complements the newly introduced DERMACYTE Oxygenating Eye Complex, which has several ingredients that target the eye contour area. The DERMACYTE skin care line uses our oxycyte technology (an oxygen carrier) to deliver oxygen to tissues, such as skin, without the use of hydrogen peroxide.
DERMACYTE Oxygenating Eye Complex is an enriched oxygen emollient infused with avocado essence, soothing oat kernel, seed extract from the meadowfoam plant, Vitamin C, sunflower oil and calming high ash. These ingredients help improve hydration and prevent water loss, while protecting your skin against environmental stress, flakiness, dryness, discoloration and puffiness in the eye area. It is hypoallergenic, paraben-free and reinforces the appearance of skin firmness and tone around the eye area. Visit for details on both products.
Oxygen Benefits Your Skin
Oxygen is essential for radiant, young-looking skin. It assists in the production of collagen and elastin, as well as with skin repair and regeneration. As we age, the body's ability to deliver oxygen to dermal tissue deteriorates. A lack of oxygen at the cellular level can cause skin to age prematurely, increasing the appearance of fine lines and age spots, making skin look dry and dull. Oxygen therapies enhance the overall appearance and feel of your skin, leaving it smoother and healthier-looking.
About the Conference
The Spa & Resort/Medical Aesthetics Expo () gives spa, aesthetic and wellness professionals the tools to move their spa business forward with incomparable networking opportunities and hands-on training and discovery of the most cutting-edge products, treatments, and services available in the industry today. Skin care and rejuvenation, mineral make-up, tanning products, robes and linens, aromatherapy, injectables, as well as nutritious food and beverages and spa apparel are just some of the products and services on display. Attendees include spa/medical aesthetics owners and professionals, estheticians, dermatologists, dentists, plastic surgeons, wellness practitioners, nutritionists and holistic therapists.
Attendees at the conference can also register for the HBA Global Expo & Conference, which takes place at the same location September 29-30. HBA Global Expo & Conference () is the largest product development event for the cosmetics, personal care, skin care, fragrance and wellness industries and features more than 600 educational and exhibitor partners. Exhibitors include international suppliers of raw materials and ingredients, packaging materials, dispensing systems, private label and contract manufacturers and testing equipment. The three-day conference program is renowned for providing cutting-edge information on the latest industry trends, new product developments, marketing and branding know-how, as well as the latest in naturals, packaging design, global distribution, and technical advancements.
About Oxygen Biotherapeutics, Inc.
Oxygen Biotherapeutics, Inc. is developing medical and cosmetic products that efficiently deliver oxygen to tissues in the body. The Company has developed a proprietary perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product called Oxycyte® that is being formulated for both intravenous and topical delivery for conditions including but not limited to traumatic brain injury, decompression sickness and topical wounds, as well as for personal skin care. More information is available at .
The Oxygen Biotherapeutics, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7277
The DERMACYTE logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7792
Caution Regarding Forward-Looking Statements
This news release contains certain forward-looking statements by the company that involve risks and uncertainties and reflect the company's judgment as of the date of this release. These statements include those referring to the plans for the expansion of the DERMACYTE product line and the timing of the introduction of those new products. Matters beyond the company's control could lead to delays in the new product introductions and customer acceptance of these new products. Furthermore, there can be no assurance that such plans will lead to meaningful sales of DERMACYTE or generate any revenue for the company. The company disclaims any intent or obligation to update these forward-looking statements beyond the date of this release. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
CONTACT: Oxygen Biotherapeutics, Inc. Ellen Corliss, Vice President Corporate Communications & Investor Relations 919-855-2112